Production of Clostridium difficile toxin in a medium totally free of both animal and dairy proteins or digests

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 32, 2009, Pages 13225-13229

  Fang, Aiqi ^a,b   Gerson, Donald F ^a,c   Demain, Arnold L ^a,d  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b 5626 RFD ^*  (United States)

^c PnuVax Inc   (Canada)

^d DREW UNIVERSITY   (United States)

Author keywords

Fermentation medium; TcdA; Toxin A

Indexed keywords

CLOSTRIDIUM DIFFICILE TOXIN A; PEPTONE; SOY PEPTONE A3; SOYBEAN PROTEIN; TRYPTONE; UNCLASSIFIED DRUG;

ANAEROBIC DIGESTION; ARTICLE; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; CULTURE MEDIUM; DAIRY PRODUCT; DRUG SYNTHESIS; FERMENTATION MEDIUM; HYDROLYSIS; MEAT; NONHUMAN; PRION DISEASE; PRIORITY JOURNAL; TITRIMETRY;

ANIMALS; BACTERIAL TOXINS; BIOREACTORS; CARBON; CLOSTRIDIUM DIFFICILE; CULTURE MEDIA; DAIRY PRODUCTS; FERMENTATION; GLUCOSE; GLYCEROL; MANNITOL; PEPTONES; PROTEINS; SOYBEAN PROTEINS;

ANIMALIA; BACTERIA (MICROORGANISMS); CLOSTRIDIUM DIFFICILE;

EID: 69449083997     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0906425106     Document Type: Article

References (27)

1. Songer JG (2004) The emergence of Clostridium difficile as a pathogen of food animals. Anim Health Res Rev 5:321-326.
2. Johnson S, et al. (1990) Nosocomial Clostridium difficile colonisation and disease. Lancet 336:97-100. (Pubitemid 20222816)
3. McFarland LV, Mulligan ME, Kwok RY, Stamm WE (1989) Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 320:204-210. (Pubitemid 19034145)
4. Warny M, et al. (2005) Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-1084. (Pubitemid 41338761)
5. Voth DE, Ballard JD (2005) Clostridium difficile toxins: Mechanism of action and role in disease. Clin Rev Microbiol 18:247-263.
6. Rupnik M, et al. (2005) Revised nomenclature of Clostridium difficile toxins and associated genes. J Med Microbiol 54:113-117. (Pubitemid 40867994)
7. Karlsson S, Burman LG, Akerlund T (1999) Suppression of toxin production in Clostridium difficile VPI 10463 by amino acids. Microbiology 145:1683-1693. (Pubitemid 29352012)
8. Dupuy B, Sonenshein AL (1998) Regulated transcription of Clostridium difficile toxin genes. Mol Microbiol 27:107-120. (Pubitemid 28022581)
9. Holbrook, WP, Duerden BL, Deacon AG (1977) The classification of Bacteroides melaninogenicus and related species. J Appl Bacteriol 42:259-273. (Pubitemid 8094797)
10. Rolfe RD, Finegold SM (1979) Purification and characterization of Clostridium difficile toxin. Infect Immun 25:191-201. (Pubitemid 9226962)
11. al Saif N, Brazier JS (1996) The distribution of Clostridium difficile in the environment of South Wales. J Med Microbiol 45:133-137.
12. Braun M, et al. (2000) Detection of the ADP-ribosyltransferase toxin gene (cdt A) and its activity in Clostridium difficile isolates from Equidae. FEMS Microbiol Lett 184:29-33. (Pubitemid 30109575)
13. Onderdonk AB, Low BR, Bartlett JG (1979) Effect of environmental stress on Clostridium difficile toxin levels during continuous cultivation. Appl Environ Microbiol 38:637-641.
14. Haslam SC, et al. (1986) Growth of Clostridium difficile and production of toxins A and B in complex and defined media. J Med Microbiol 21:293-297.
15. Osgood CP, Wood NP, Sperry JF (1993) Nutritional aspects of cytotoxin production by Clostridium difficile. Appl Environ Microbiol 59:3985-3988.
16. Demain AL, Gerson D, Fang A (2005) Effective levels of tetanus toxin can be made in a production medium totally lacking both animal (e.g., brain heart infusion) and dairy proteins or digests (e.g., casein hydrolysates). Vaccine 23:5420-5423. (Pubitemid 41579314)
17. Demain AL, Gerson DF, Kole M, Fang, A (2006) The role of reduced iron powder in the fermentative production of tetanus toxin. Appl Microbiol Biotechnol 73:55-59. (Pubitemid 44627724)
18. Fang A, Gerson DF, Demain AL (2006) Menstrum for culture preservation and medium for seed preparation in a tetanus toxin production process containing no animal or dairy products. Lett Appl Microbiol 43:360-363. (Pubitemid 44379178)
19. Demain AL, George S, Kole M, Gerson DF, Fang A (2007) Tetanus toxin production in soy-based medium: Nutritional studies and scale-up into small fermentors. Lett Appl Microbiol 45:635-638. (Pubitemid 350150779)
20. Mikola M, Sato J, Amanullah A (2007) Evaluation of a novel Wave bioreactor cellbag for aerobic yeast cultivation. Bioproc Biosyst Engr 30:231-241. (Pubitemid 47020023)
21. Hundsberger T, et al. (1997) Transcription analysis of the genes tcdA-E of the pathogenicity locus of Clostridium difficile. Eur J Biochem 244:735-742.
22. Mani N, Dupuy B (2001) Regulation of toxin synthesis in Clostridium difficile by an alternative RNA polymerase sigma factor. Proc Natl Acad Sci USA 98:5844-5849. (Pubitemid 32435730)
23. Wisher M (2002) Biosafety and product release testing relevant to replication-competent oncolytic viruses. Cancer Gene Ther 9:1056-1061.
24. Scott JP, Brandly CA (1932) The use of reduced iron for the cultivation of anaerobic organisms. J Bacteriol 26:1-7.
25. Thomas WD, Giannasca PJ, Zhang Z, Lei W, Monath TP (2005) Active immunization against Clostridium difficile disease. US Patent 6969520.
26. Garnier T, Cole ST (1986) Characterization of a bacteriocinogenic plasmid from Clostridium perfringens and molecular genetic analysis of the bacteriocin-encoding gene. J Bacteriol 168:1189-1196. (Pubitemid 17226802)
27. Redound SC, et al. (1985) Detection of Clostridium difficile enterotoxin (toxin A) by ELISA and other techniques, In Isolation and Identification of Microorganisms of Medical and Veterinary Importance, eds Collins CH and Grange JM (Society of Applied Bacteriology Technical Series No. 21, Academic, London), pp 237-250.